mail
versión imprimible
 
 

3rd Glioblastoma Drug Development Summit

Evvnt Promotion / evvnt
-
18.01.2022 - 20.01.2022  Wyndham Boston Beacon Hill, 5 Blossom Street, 02114 Boston, USA
Time: 8:00 AM - 5:40 PM
 
Temas de la conferencia
Together we will increase the length and quality of patient survival from diagnosis.

The 3rd Glioblastoma Drug Development Summit is the only industry led forum for large pharma, biotech and academic KOLs to unite under the common goal of accelerating the practical translation and clinical development of meaningful therapies for the treatment of glioblastoma.
Organizador profesional (PCO)
Hanson Wade
 

Información e inscripción:

https://go.evvnt.com/882097-2?pid=4832
Ms. Ellie Saunders
 
Categorías
Medicina General
Idioma
Inglés
Cuota del Congreso
USD 1299.00 - USD 2199.00
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."

OÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation Charité International AcademyÖsterreichische Akademie der ÄrzteHilfswerk AustriaHelix - Forschung & Beratung WienCenter of ExcellenceSwiss Tropical and Public Health InstituteEuropean Health Forum Gastein